Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs AT&T Inc. (T) Price & Performance

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs AT&T Inc. — how do they compare? Novo Nordisk A/S trades at $45.93 (market cap $207.85B), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: Novo Nordisk A/S is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (4.53%). Which is the better fit depends on your goals.

NVOT
Market Cap
$207.85B$167.88B
Sector
HealthMedia
52-Week High
$63.98$29.62
52-Week Low
$35.29$20.49
Enterprise Value
$222.55B$313.20B
Dividend Yield
3.81%4.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T